Company intelligence / Profile preview
Stemcelline
Indiastemcelline.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Offers regenerative cell therapy and exosome products for a range of degenerative, autoimmune, and hereditary diseases; claims promising results but no peer-reviewed clinical data is referenced in the sources
- Therapeutic areas
- ImmunologyNeurologyRare Diseases
- Modalities
- Stem cell therapyExosome-based therapyRegenerative cell therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Stemcelline.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Stemcelline.